Asia Pacific Biopharmaceutical Contract Manufacturing Market is expected to reach US$ Asia Pacific 315.0 Bn by 2027 with CAGR of 6.9%.

All News News

The growth of the market is driven by factors such as the increasing outsourcing by pharmaceutical companies and increasing demand of biologics in the European region. However, increasing competition in the industry is likely to restrain the market growth to a certain extent.

Manufacturing of Biopharmaceutical medicines through contract manufacturer from DNA to finished final product. Contract manufacturing is the type of outsourcing where a company enters into an agreement or legal settlement with another manufacturing firm for products, parts, or components, which the former will then use in its production process to complete its product. This involves manufacturing of biopharmaceutical molecules, proteins, nucleic acids, blood components, and vaccines developed from a biological source. These companies are specialized in the production of molecules and offer different types of services such as Development Process, Analytical and Quality Control among others.

Get free trial subscription and gain instant access to our market research reports at

The contract manufacturing market for biologics is growing at an unprecedented rate owing to increasing biologics pipeline, manufacturing complexity, and companies shifting their focus towards core activities. The outsourcing is required to expedite research and development, speed up market entry, give access to novel technologies, regulatory expertise, and reduces risks at a competitive cost. Complexities in biologics development and production and increasingly stringent quality standards have driven drug manufactures to prefer contract manufacturer services.

A significant boom has been witnessed in the contract manufacturing of biologics. This can be attributed to difficulties in the production of a large-scale biologics in house. For instance, Sanofi has outsourced the manufacturing of its biologics pipeline to Boehringer Ingelheim. Many companies are opting CMOs services to speed up the development process and lower production costs. Also, due to the growing demand for biologics, Rentschler is looking to expand globally, adding a new facility to its site in Laupheim, Germany, to expand its capacity. It invested about €24 million to add two 3,000-liter stainless steel bioreactors, more than doubling its capacity. Thus, increasing demand of biologics is expected to drive the growth of the in Europe during the forecast period.

The Business Market Insights subscription helps clients understand the ongoing market trends, identify opportunities, and make informed decisions through the reports in the Subscription Platform. The Industry reports available in the subscription provide an in-depth analysis on various market topics and enable clients to line up remunerative opportunities. The reports provide the market size & forecast, drivers, challenges, trends, and more.

US is anticipated to leads the Biopharmaceutical Contract Manufacturing market across the North America region through the forecast period. The growth in SIEM in the U.S. is mainly driven by factors which includes its state of being one of the best internet connected countries in the world, with around 85% of its population using internet in 2018; in addition, the country is also ranked second globally for online B2C transactions; and, the ever-increasing cybercrime costs that had reached $100 billion in the US in 2014, which is nearly one-fourth of the $445 billion, all these aspects are owing to significant growth of SIEM market. This will further propel the growth of manufacturing industry in the country thereby, accelerating the growth of Biopharmaceutical Contract Manufacturing market in the U.S.

Business Market Insights reports focus upon client objectives, use standard research methodologies and exclusive analytical models, combined with robust business acumen, which provides precise and insightful results.

Business Market Insights reports are useful not only for corporate and academic professionals but also for consulting, research firms, PEVC firms, and professional services firms.

Full Report subscription with pay as per requirement at

(30-day subscription plans prove to be very cost-effective with no compromise on the quality of reports)

Europe Biopharmaceutical Contract Manufacturing Market – By Product


Monoclonal Antibodies

Recombinant Proteins




Europe Biopharmaceutical Contract Manufacturing Market – By Service

Development Process

Final Dosage Operation

Analytical and Quality Control

Final Packaging

Europe Biopharmaceutical Contract Manufacturing Market – By Country






Europe Biopharmaceutical Contract Manufacturing Market – Companies Mentioned

Lonza Group AG

Boehringer Ingelheim International GmbH

Inno Biologics Ventures Sdn Bhd

Thermo Fisher Scientific

AbbVie Inc.

WuXi Biologics

General Electric

Samsung Biologics

Merck KGaA

Ajinomoto Co., Inc

Benefits with Business Market Insights

  • One Stop Platform to All the Market Insight Needs
  • Avoid Long Purchase Procedures
  • Fast and Easy Access
  • Cloud-Based Platform
  • News Updates
  • Ask the Analyst Support
  • Pay Monthly Subscription and Access All You Want
  • No Compulsion for Yearly Subscription
  • Reports Read or Download Access
  • Monthly New Reports Added
  • Affordable Product, Pay as Per Requirement

About Business Market Insights

Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Technology, Media and Telecommunications  IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.

For Subscription contact

Business Market Insights

Phone : +442081254005
E-Mail : [email protected]